ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

APVO Aptevo Therapeutics Inc

0.43
-0.041 (-8.70%)
20 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Aptevo Therapeutics Inc NASDAQ:APVO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.041 -8.70% 0.43 0.31 0.4711 0.548 0.42 0.4621 11,492,814 05:00:05

Initial Statement of Beneficial Ownership (3)

06/11/2020 9:48pm

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

TANG KEVIN C
2. Date of Event Requiring Statement (MM/DD/YYYY)
11/4/2020 

3. Issuer Name and Ticker or Trading Symbol

Aptevo Therapeutics Inc. [APVO]
(Last)        (First)        (Middle)

4747 EXECUTIVE DRIVE, SUITE 210
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

SAN DIEGO, CA 92121      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 323325 I By LP (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
TANG KEVIN C
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO, CA 92121

X

TANG CAPITAL MANAGEMENT LLC
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO, CA 92121

X

TANG CAPITAL PARTNERS LP
4747 EXECUTIVE DRIVE
SUITE 210
SAN DIEGO, CA 92121

X


Signatures
/s/ Kevin Tang11/6/2020
**Signature of Reporting PersonDate

/s/ Kevin Tang, Managing Member11/6/2020
**Signature of Reporting PersonDate

/s/ Kevin Tang, Managing Member of Tang Capital Management, LLC, General Partner11/6/2020
**Signature of Reporting PersonDate

1 Year Aptevo Therapeutics Chart

1 Year Aptevo Therapeutics Chart

1 Month Aptevo Therapeutics Chart

1 Month Aptevo Therapeutics Chart

Your Recent History

Delayed Upgrade Clock